List of Tables
Table 1. Global Cancer Drug Therapy Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cancer Drug Therapy Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Cancer Drug Therapy Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cancer Drug Therapy Covered in This Study
Table 5. Global Cancer Drug Therapy Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Cancer Drug Therapy Sales Share by Manufacturers (2016-2021)
Table 7. Global Cancer Drug Therapy Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cancer Drug Therapy Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cancer Drug Therapy Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cancer Drug Therapy Manufacturing Sites and Area Served
Table 11. Manufacturers Cancer Drug Therapy Product Type
Table 12. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Drug Therapy as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cancer Drug Therapy Sales by Region (2016-2021) & (K Units)
Table 16. Global Cancer Drug Therapy Sales Market Share by Region (2016-2021)
Table 17. Global Cancer Drug Therapy Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cancer Drug Therapy Sales by Country (2016-2021) & (K Units)
Table 19. North America Cancer Drug Therapy Sales Market Share by Country (2016-2021)
Table 20. North America Cancer Drug Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cancer Drug Therapy Revenue Market Share by Country (2016-2021)
Table 22. Europe Cancer Drug Therapy Sales by Country (2016-2021) & (K Units)
Table 23. Europe Cancer Drug Therapy Sales Market Share by Country (2016-2021)
Table 24. Europe Cancer Drug Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cancer Drug Therapy Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cancer Drug Therapy Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Cancer Drug Therapy Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cancer Drug Therapy Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cancer Drug Therapy Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Cancer Drug Therapy Sales Market Share by Country (2016-2021)
Table 32. Latin America Cancer Drug Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cancer Drug Therapy Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cancer Drug Therapy Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Cancer Drug Therapy Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cancer Drug Therapy Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Country (2016-2021)
Table 38. Global Cancer Drug Therapy Sales (K Units) by Type (2016-2021)
Table 39. Global Cancer Drug Therapy Sales Market Share by Type (2016-2021)
Table 40. Global Cancer Drug Therapy Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cancer Drug Therapy Revenue Share by Type (2016-2021)
Table 42. Global Cancer Drug Therapy Price (USD/Unit) by Type (2016-2021)
Table 43. Global Cancer Drug Therapy Sales (K Units) by Application (2016-2021)
Table 44. Global Cancer Drug Therapy Sales Market Share by Application (2016-2021)
Table 45. Global Cancer Drug Therapy Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cancer Drug Therapy Revenue Share by Application (2016-2021)
Table 47. Global Cancer Drug Therapy Price (USD/Unit) by Application (2016-2021)
Table 48. Amgen / Allergan Corporation Information
Table 49. Amgen / Allergan Description and Business Overview
Table 50. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Amgen / Allergan Cancer Drug Therapy Product
Table 52. Amgen / Allergan Recent Developments/Updates
Table 53. Argos Therapeutics Corporation Information
Table 54. Argos Therapeutics Description and Business Overview
Table 55. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Argos Therapeutics Cancer Drug Therapy Product
Table 57. Argos Therapeutics Recent Developments/Updates
Table 58. AstraZeneca Corporation Information
Table 59. AstraZeneca Description and Business Overview
Table 60. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. AstraZeneca Cancer Drug Therapy Product
Table 62. AstraZeneca Recent Developments/Updates
Table 63. Aveo Pharmaceuticals Corporation Information
Table 64. Aveo Pharmaceuticals Description and Business Overview
Table 65. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Aveo Pharmaceuticals Cancer Drug Therapy Product
Table 67. Aveo Pharmaceuticals Recent Developments/Updates
Table 68. Bayer Corporation Information
Table 69. Bayer Description and Business Overview
Table 70. Bayer Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Bayer Cancer Drug Therapy Product
Table 72. Bayer Recent Developments/Updates
Table 73. Exelixis Corporation Information
Table 74. Exelixis Description and Business Overview
Table 75. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Exelixis Cancer Drug Therapy Product
Table 77. Exelixis Recent Developments/Updates
Table 78. Incyte Corporation Information
Table 79. Incyte Description and Business Overview
Table 80. Incyte Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Incyte Cancer Drug Therapy Product
Table 82. Incyte Recent Developments/Updates
Table 83. Merck Corporation Information
Table 84. Merck Description and Business Overview
Table 85. Merck Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Merck Cancer Drug Therapy Product
Table 87. Merck Recent Developments/Updates
Table 88. Roche Corporation Information
Table 89. Roche Description and Business Overview
Table 90. Roche Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Roche Cancer Drug Therapy Product
Table 92. Roche Recent Developments/Updates
Table 93. Bristol-Myers Squibb Corporation Information
Table 94. Bristol-Myers Squibb Description and Business Overview
Table 95. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Bristol-Myers Squibb Cancer Drug Therapy Product
Table 97. Bristol-Myers Squibb Recent Developments/Updates
Table 98. Eisai Corporation Information
Table 99. Eisai Description and Business Overview
Table 100. Eisai Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Eisai Cancer Drug Therapy Product
Table 102. Eisai Recent Developments/Updates
Table 103. Exelixis Corporation Information
Table 104. Exelixis Description and Business Overview
Table 105. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Exelixis Cancer Drug Therapy Product
Table 107. Exelixis Recent Developments/Updates
Table 108. Genentech (Roche) Corporation Information
Table 109. Genentech (Roche) Description and Business Overview
Table 110. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Genentech (Roche) Cancer Drug Therapy Product
Table 112. Genentech (Roche) Recent Developments/Updates
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Novartis Cancer Drug Therapy Product
Table 117. Novartis Recent Developments/Updates
Table 118. Pfizer Corporation Information
Table 119. Pfizer Description and Business Overview
Table 120. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Pfizer Cancer Drug Therapy Product
Table 122. Pfizer Recent Developments/Updates
Table 123. Prometheus Labs Corporation Information
Table 124. Prometheus Labs Description and Business Overview
Table 125. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Prometheus Labs Cancer Drug Therapy Product
Table 127. Prometheus Labs Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Cancer Drug Therapy Distributors List
Table 131. Cancer Drug Therapy Customers List
Table 132. Cancer Drug Therapy Market Trends
Table 133. Cancer Drug Therapy Growth Drivers
Table 134. Cancer Drug Therapy Market Restraints
Table 135. Global Cancer Drug Therapy Sales Forecast by Type (2022-2027) & (K Units)
Table 136. Global Cancer Drug Therapy Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Cancer Drug Therapy Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Cancer Drug Therapy Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Cancer Drug Therapy Sales Forecast by Application (2022-2027) & (K Units)
Table 140. Global Cancer Drug Therapy Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Cancer Drug Therapy Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Cancer Drug Therapy Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Cancer Drug Therapy Sales Forecast by Region (2022-2027) & (K Units)
Table 144. Global Cancer Drug Therapy Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Cancer Drug Therapy Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Cancer Drug Therapy Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cancer Drug Therapy
Figure 2. Global Cancer Drug Therapy Market Share by Type in 2020 & 2027
Figure 3. Targeted Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Global Cancer Drug Therapy Market Share by Application in 2020 & 2027
Figure 7. Angiogenesis Inhibitors
Figure 8. mTOR Inhibitors
Figure 9. Monoclonal Antibodies
Figure 10. Cytokine Immunotherapy (IL-2)
Figure 11. Global Cancer Drug Therapy Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer Drug Therapy Market Size 2016-2027 (US$ Million)
Figure 13. Global Cancer Drug Therapy Sales 2016-2027 (K Units)
Figure 14. Global Cancer Drug Therapy Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Cancer Drug Therapy Sales Share by Manufacturers in 2020
Figure 16. Global Cancer Drug Therapy Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Cancer Drug Therapy Players: Market Share by Revenue in 2020
Figure 18. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Cancer Drug Therapy Sales Market Share by Region (2016-2021)
Figure 20. Global Cancer Drug Therapy Sales Market Share by Region in 2020
Figure 21. Global Cancer Drug Therapy Revenue Market Share by Region (2016-2021)
Figure 22. Global Cancer Drug Therapy Revenue Market Share by Region in 2020
Figure 23. U.S. Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Cancer Drug Therapy Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Cancer Drug Therapy by Type (2016-2021)
Figure 48. Sales Market Share of Cancer Drug Therapy by Application (2016-2021)
Figure 49. Sales Market Share of Cancer Drug Therapy by Application in 2020
Figure 50. Revenue Share of Cancer Drug Therapy by Application (2016-2021)
Figure 51. Revenue Share of Cancer Drug Therapy by Application in 2020
Figure 52. Manufacturing Cost Structure of Cancer Drug Therapy
Figure 53. Manufacturing Process Analysis of Cancer Drug Therapy
Figure 54. Cancer Drug Therapy Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

LIST OF FIGURE